Aim: The influence of schizophrenic patients' functional disability on cancer screening participation worldwide is unclear. There are few findings on the disparities in schizophrenic patients' participation in cancer screening programs in Asia. The aim of this study was to investigate the screening rate and the associations between screening and symptom severity/ functional disability in patients with schizophrenia.
Aim: The influence of schizophrenic patients' functional disability on cancer screening participation worldwide is unclear. There are few findings on the disparities in schizophrenic patients' participation in cancer screening programs in Asia. The aim of this study was to investigate the screening rate and the associations between screening and symptom severity/ functional disability in patients with schizophrenia.
Methods: This cross-sectional study was conducted in a psychiatric hospital outpatient clinic in Japan. We recruited schizophrenic patients meeting the national program criteria for cancer screening for colorectal, gastric, lung, breast, and cervical cancer (n = 224, 223, 224, 110, and 175, respectively). Receipt of cancer screenings was assessed using a self-report questionnaire. Scores on the modified Global Assessment of Functioning (mGAF) were evaluated by participants' primary psychiatrists.
Results: Rates of cancer screenings were as follows: 24.1% for colorectal, 21.5% for gastric, 30.8% for lung, 25 .5% for breast, and 19.4% for cervical cancer. A multivariable logistic analysis showed that a 1-point increase in severity/disability (100 minus mGAF score) was associated with significantly lower odds ratios (OR) for receipt of cancer screenings, 
Conclusion:
The findings demonstrated low rates of cancer screenings in schizophrenic patients in Japan. Our study suggests the need to encourage attendance at cancer screenings, especially in schizophrenic patients with severe symptoms/functional disability.
risk of death compared with individuals in the general population; this mortality gap has been attributed to increased risks for both suicide and natural death, including death from cancer. [2] [3] [4] Therefore, cancer screenings, which are effective in reducing cancer death, are important preventive health-care measures. [5] [6] [7] However, of 10 studies we reviewed on cancer screening in individuals with schizophrenia, eight indicated a low rate of receipt of cancer screenings, including breast, [8] [9] [10] [11] [12] cervical, 8, 9, [12] [13] [14] [15] [16] and colorectal cancer screenings. 17 Most previous studies on this issue have been conducted in North America and Europe on participants of non-Asian culture and ethnicity. To our knowledge, no studies have examined gastric cancer screening behavior in people with schizophrenia. East Asian countries have higher incidence and mortality rates of gastric cancer and more than 50% of cases occur in Eastern Asia. 18 North America and European countries have relatively high rates of cancer screenings in the general population compared with other developed and developing countries; 19 therefore, the applicability of previous findings to countries with lower rates of cancer screenings for the general population is debatable.
Findings on the association between symptom severity and/or functional disability and receipt of cancer screenings in schizophrenic patients are controversial. Carney and Jones 13 showed that patients with psychotic disorders had decreased odds for receipt of mammography in their register-based study, regardless of history of hospitalization for mental disorder or comorbid substance abuse, which the authors assumed was a surrogate marker of illness severity. However, an association between clinician-assessed severity/disability (i.e., a nonsurrogate marker of illness severity) and receipt of cancer screenings in schizophrenic patients has not yet been reported. Moreover, the only previous studies investigating this association in people with schizophrenia are on mammography screening. Of three previous studies of individuals with mental illness not restricted to schizophrenia, two found a significant association between higher clinicianassessed severity/disability and non-receipt of cancer screenings, and one study found a non-significant association. [20] [21] [22] The objectives of the present study were: (i) to investigate the rates of cancer screenings; (ii) to examine the associations between severity/disability and receipt of cancer screenings; and (iii) to explore the factors related to receipt of cancer screenings in schizophrenic patients in a psychiatric outpatient service. The advantages of the present study are that it was conducted in an Asian country and that severity/disability was based on a clinician rating scale that has demonstrated good validity.
METHODS

Study design
The present study was part of the Study of Health Behavior in People with Schizophrenia (SHEAPS), which is registered in a clinical trial registry (UMIN000023874). The SHEAPS has a crosssectional design with two related aims investigating: (i) cancer screening behaviors; and (ii) smoking behaviors in patients with schizophrenia. It was conducted in an outpatient psychiatric clinic (descriptions of the setting and participants are as follows).
Setting
Participants in the SHEAPS were recruited in a psychiatric outpatient clinic at the Okayama Psychiatric Medical Center in Japan. The Okayama Psychiatric Medical Center (252 beds and approximately 250 outpatient visits per day) is the core public psychiatric hospital in Okayama prefecture and provides services ranging from outpatient psychiatric care to acute inpatient psychiatric care in this regional urban area.
Participants
The SHEAPS inclusion criteria were as follows. On 1 April 2016, patients: (i) were aged 20-69 years; (ii) had visited the Okayama Psychiatric Medical Center for 1 or more years and had visited the hospital twice or more in the last 6 months as their primary psychiatric outpatient service; and (iii) at the time of eligibility assessment (July 2016), had been diagnosed by their current primary psychiatrists with schizophrenia or schizoaffective disorder (but not other schizophrenia spectrum disorders) based on their chart review and current/past psychiatric interviews, according to the DSM-5. 23 The exclusion criteria were as follows: (i) patients comorbid for intellectual disabilities and unable to answer the questionnaires; (ii) those with psychiatric symptoms too severe to make study participation appropriate (as judged by their primary psychiatrists); (iii) those incapable of study participation because their physical status was too severe (as judged by their primary psychiatrists); and (iv) those unable to read or write in Japanese. In accordance with the criteria, 680 patients were pooled as eligible participants from the hospital records and judgments by their primary psychiatrists.
A total of 420 patients were randomly extracted in August 2016 from the patients' pool (n = 680) using computer-generated random numbers assigned to each individual by a researcher blinded to the background characteristics of patients (except for study ID). The authors asked potential participants to participate in the SHEAPS from September to November 2016. Most participants were contacted by researchers about SHEAPS participation at their clinic visits. The researchers also attempted to increase the participation rate using telephone and mail to approach those potential participants they could not contact at the outpatient clinic.
To analyze cancer screening behavior, which is one of the aims of the SHEAPS, we identified all SHEAPS participants who met the criteria of recommendation for receipt of cancer screenings by the Ministry of Health, Labour, and Welfare (MHLW). The analysis of screening behavior for each type of cancer excluded individuals with a history of that particular cancer (e.g., the analysis of gastric cancer screening behavior excluded patients with a history of gastric cancer but included those with a history of colorectal, lung, breast, or cervical cancer).
Outcomes
The outcomes analyzed in the present study were pre-planned in the SHEAPS. The primary outcome of this study was the rate of cancer screenings. The secondary outcomes were the associations of symptom severity/functional disability and other patient characteristics with receipt of cancer screenings.
Data source and measurements
Sex and age data were obtained from medical records. Educational level, employment status, marital status, the presence or absence of current visits to other outpatient clinics for any physical illness, the presence or absence of a history of cancer, and receipt of cancer screenings were self-reported on a questionnaire. The researchers (M. F. and M. I., psychiatrists) and a trained research assistant (who was licensed as a nurse) helped participants to complete the questionnaires as needed.
Cancer screening
The questionnaire developed by Shibuya et al. 24 was used in the SHEAPS. Participants were asked about receipt of the following cancer screenings recommended by the MHLW in 2015: fecal occult blood testing, upper gastrointestinal X-ray, chest X-ray for people aged 40 years or older within 1 year, mammography for women aged 40 years or older within 2 years, and Pap smear test for women aged 20 years or older within 2 years. In addition, the questionnaire asked about receipt of the following cancer screening tests not included in the list of cancer screenings recommended by the MHLW in 2015: sigmoidoscopy/colonoscopy and upper endoscopy for people aged 40 years or older within 1 year, and breast ultrasound for women aged 40 years or older within 2 years. This questionnaire was validated by comparing responses with the results of telephone interviews from a previous study. 24 
Symptom severity and functional disability
Patient symptom severity and functional disability were assessed by the primary psychiatrists using the modified Global Assessment of Functioning (mGAF). 25 The mGAF is an observer-rated numeric scale with a score range of 1-100. Higher scores reflect higher functioning. The mGAF scores are based on psychological, social, and occupational functioning. The mGAF was developed to improve the reliability and validity of the original GAF and has more detailed criteria and a more structured scoring system than the original scale. 25 We used the Japanese version of the mGAF, which has good reliability and validity. 26 We used mGAF scores for the best month in the last year. The mGAF score was converted (to 100 minus mGAF score) for analysis so that higher scores indicated more severe functional disability.
Sample size
The SHEAPS was an exploratory survey; the authors planned to sample 420 subjects drawn by random sampling from pooled eligible SHEAPS participants (the largest sample possible given our resources in the current setting). The current analysis population was extracted from the SHEAPS participants.
Ethical approval
The SHEAPS was approved by the institutional ethics committee at the Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences and Okayama University Hospital (receipt number KEN1608-010), and by Okayama Psychiatric Medical Center (receipt number 27-38). Potential participants were informed that they could refuse to participate or withdraw from the study at any time and provided informed written consent.
Statistical analysis
Data were analyzed using SPSS version 22 (IBM, Tokyo, Japan). We described the characteristics of the participants nationally recommended for each type of cancer screening (Table 1) . We calculated the rate of cancer screening and 95% confidence intervals (CI) for each cancer screening site. In addition, we calculated cancer screening rates adjusted according to the age structure of the population of Okayama city in 2013. We used this population because: (i) about 60% of our participants lived in the area; and (ii) the most recent available data on cancer screening rates for external reference were reported in a 2013 MHLW national survey. 27 We also calculated the screening rates for each type of cancer for samples that included participants with a history of that particular cancer (e.g., the analysis of gastric cancer screening behavior included patients with a history of gastric cancer) Table 1 . Characteristics of the participants nationally recommended for each cancer screening in the sample of 420 We also conducted univariable and multivariable logistic regression analyses to explore the association of severity/disability and other patient characteristics with receipt of cancer screenings. For the univariable analysis, we calculated the odds ratio (OR) and 95% CI of receipt of cancer screenings for severity/disability (100 minus mGAF score: continuous variable), age category, sex, educational level category, marital status category, and the presence or absence of current visits to other outpatient clinics for any physical illness. This latter variable might be associated with receipt of cancer screening because patients also visiting other outpatient clinics for physical illness may have had more exposure to information on preventive health care, including cancer screening, than patients not undergoing such visits. A previous study showed that the number of non-mental-health-care visits to primary care providers was associated with receipt of cancer screening among people with mental illness. 13 For the multivariable analysis, we calculated adjusted OR of severity/disability with adjustment for age, sex, educational level, marital status, and current outpatient visits for any physical illness. We excluded employment status from the covariates in the multivariable analysis because there was a high correlation between employment status and mGAF score including occupational function as the anchor point. Figure 1 shows the study recruitment process. Data were analyzed for 224 participants out of 269 patients who met the recommended criteria for colorectal cancer screening, 223 participants out of 268 patients for gastric cancer screening, 224 participants out of 269 patients for lung cancer screening, 110 participants out of 137 patients for breast cancer screening, and 175 participants out of 213 patients for cervical cancer screening; participation rates were 83.3%, 83.2%, 83.3%, 80.3%, and 82.2%, respectively. Table 1 shows the characteristics of participants recommended for each cancer screening. Table 2 shows the crude and age-adjusted rates and 95%CI. For ease of comparison, we have included both external reference data and our sample data. The crude (adjusted) rates of cancer screening in our schizophrenic patients were as follows:
RESULTS
24.1% (25.1%) for colorectal, 21.5% (20.6%) for gastric, 30.8% (31.1%) for lung, 25.5% (25.6%) for breast, and 19.4% (20.0%) for cervical cancer. We also calculated the cancer screening rates using samples that included participants with a history of each cancer for comparison; the adjusted rates were as follows: 25.1% for colorectal, 20.5% for gastric, 31.1% for lung, 24.3% for breast, and 20.0% for cervical cancer. There were few differences between rates calculated from samples that included patients with a history of cancer and those calculated from samples that did not. Table 3 shows the crude OR from the univariable analysis and adjusted OR from the multivariable analysis for receipt of each type of cancer screening. In both the univariable and multivariable analyses, severity/disability showed a significantly inverse association with receipt of cancer screenings except for breast cancer screening (P = 0.054 and 0.073, respectively).
Age, sex, and educational level had no statistically significant association with any cancer screenings in either of the analyses. Associations of employment status, marital status, and current outpatient visits for any physical illness varied across cancer screenings (see Table 3 ).
DISCUSSION
The present findings show that only about a quarter of schizophrenic patients who had visited the psychiatric outpatient clinic received cancer screenings. To our knowledge, this is the first study to demonstrate an association between clinician-assessed severity/disability and receipt of cancer screenings in schizophrenic patients.
Based on external data reported in an MHLW national survey, 27 the rates of cancer screenings in our schizophrenic patients were approximately one-half the rates of cancer screenings among the general population of Okayama city, in which about 60% of our participants lived (Table 2 ). Even if all of the patients who did not participate in the present study had received all recommended cancer screenings, the hypothetical rates of cancer screenings in our patients would have been lower than in the general population. Our findings are consistent with those of previous studies indicating that schizophrenic patients are less likely to attend cancer screenings. One meta-analysis 28 and subsequently published studies 11, 12 have shown that women with schizophrenia and related 8, 16 Kodl et al. reported that veterans with psychotic disorder were less likely to receive colorectal cancer screening. 17 Therefore, individuals with schizophrenia might have lower rates of cancer screenings regardless of type of cancer screening tests, cultural background, and health-care systems. Disparities in receiving cancer screenings among the schizophrenic population might be a universal problem.
Our study showed statistically significant associations between symptom severity/disability and nonreceipt of cancer screenings, except for a trend-level association in a relatively small sample of women receiving breast cancer screenings. Patients with severe schizophrenia might need particular encouragement to attend cancer screenings because they might have more limited access to and availability of health information, poorer communication with their physicians, and limited family, social, and community resources.
Only a few studies have reported associations between cancer screenings and other factors in patients with schizophrenia. 10, 14 Previous studies of the general population (but not patients with schizophrenia) indicate associations between socioeconomic factors (such as educational level, income, employment status, and marital status) and receipt of cancer screenings. [29] [30] [31] [32] [33] [34] [35] However, we did not find a consistent association between these factors and receipt of cancer screenings. In addition, the association between current visits to other physical outpatient clinics and receipt of cancer screenings varied depending on cancer site. Current outpatient visits for any physical illness were associated with colorectal and gastric cancer screenings but not with lung, breast, and cervical screenings. Previous reports of the association between cancer screenings and comorbid physical illness are inconsistent. 10, 14 Although it is unclear why these associations vary according to cancer site, clinicians might need to pay attention to receipt of cancer screenings in people with schizophrenia, regardless of socioeconomic status and physician visits.
This study had several limitations. First, the selfreport data could have resulted in misclassification of receipt of cancer screenings. The rates of cancer screenings among the general population obtained from national survey data and used as external reference were also based on self-report data. Second, participants were recruited from a single outpatient clinic in a psychiatric hospital. Although our findings of low rates of cancer screenings in patients with schizophrenia are consistent with findings from studies in other settings, it is unclear whether our results are generalizable to schizophrenic patients in different settings. Third, there was a timing gap between the mGAF ratings and receipt of cancer screenings, which may have been as much as 1 year for colorectal, gastric, and lung cancer screening and 2 years for breast and cervical cancer screening. Fourth, it is not possible to assume causality between severity/disability or other variables and receipt of cancer screenings because this was a crosssectional study. However, reverse causality is unlikely in these associations. Finally, the true endpoint is cancer mortality, not cancer screening rates among patients with schizophrenia.
In conclusion, we confirmed that individuals with schizophrenia visiting a psychiatric outpatient service have low rates of cancer screenings. The disparities in cancer screenings between individuals with schizophrenia and the general population are as serious in Japan as in North America and Europe. Moreover, this study revealed that functional disability was significantly associated with non-receipt of cancer screenings, except for breast cancer. It may be relatively easy to encourage schizophrenic patients visiting a psychiatric outpatient service to attend cancer screenings because they have been followed by their primary psychiatrists, with whom they have an established relationship. Our findings might lead to future research on the development of proactive behavioral interventions to increase rates of cancer screenings in people with schizophrenia.
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